EZH2 can also inhibit astroglial differentiation and promote glioma tumourigenecity by repressing BMP Receptor1-Beta (BMPR1B) expression and BMPR1B-mediated differentiation signalling (Lee et al, 2008; Table 2). This evidence concerns the gene BMPR1B and central nervous system cancer.